Rabeprazole Sodium
- Product NDC
- 70518-2860
- 11-digit product format
- 705182860
- Labeler code
- 70518
- Product ID
- 70518-2860_dcf226cc-f216-15df-e053-2995a90a3d35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rabeprazole Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA205761
- Marketing category
- ANDA
- Marketing start
- 2020-08-26
- Marketing end
- 0000-00-00
- Substance
- RABEPRAZOLE SODIUM
- Active strength
- 20 mg/1
- Pharmacologic classes
- Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2860-0 | 70518286000 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-2860-0) | 2020-08-26 | 0000-00-00 | No | No | Current |
| 70518-2860-1 | 70518286001 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-2860-1) | 2021-01-06 | 0000-00-00 | No | No | Current |